Perianeurysmal Retroperitoneal Fibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2010-11-15
Clinical Trial Update: Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial [Phase 3]
A Phase 3 randomized multicenter trial is evaluating methotrexate as a steroid-sparing treatment for idiopathic retroperitoneal fibrosis, wi…